Skip to content

The impact of Lactofem capsules on frozen embryo transfer (FET)

Comparison of the Effect of Lactofem Probiotic Capsules and Standard Treatments on Pregnancy Success Rate in Women Undergoing Frozen Embryo Transfer (FET) Treatment

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240920063101N1
Enrollment
20
Registered
2025-02-14
Start date
2025-02-18
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Intervention group: The group receiving the probiotic in the form of Lactofem capsules, a product of the knowledge-based company, Zist Takhmir. The contents of the Lactofem capsule inc

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients who have frozen embryos and are scheduled for embryo transfer A maximum of two unsuccessful IVF cycles The patient must provide informed consent and fully understand the details, potential risks, and benefits of participating in the study

Exclusion criteria

Exclusion criteria: Body mass index above 35 Thrombophlebitis Inherited thromboembolic disorders Cerebrovascular disease Coronary artery disease or a history of these diseases Significant liver dysfunction Hepatitis Liver cancer Migraine headaches with aura Diabetes with vascular complications Suspected or known breast cancer Cigarette smoking with age over 35 years Severely elevated cholesterol or triglyceride levels (above 240 and 200 mg/dl, respectively) Uncontrolled hypertension History of peripartum cardiomyopathy Lactofem contraindications Estradiol contraindications Consumption of immunosuppressive drugs History of food or drug allergies AIDS Immune system deficiency Signs of severe infection such as nausea, vomiting, severe abdominal pain, and bloody diarrhea Treatment with chemotherapy drugs Heart valve-related diseases History of ulcerative colitis History of irritable bowel syndrome

Design outcomes

Primary

MeasureTime frame
Pregnancy success. Timepoint: after 24 days, after 34 days from probiotic or placebo started. Method of measurement: b-hCG test, ultrasound for gestational sac visualization, and ultrasound for fetal heart activity visualization.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Ghamsari

Kashan University of Medical Sciences

ghamsari.p@gmail.com+98 31 5558 9444

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026